Although we may not have sufficient power to detect significant changes in our secondary outcomes (tau PET, MRIs, CSF AD biomarkers and cognition), including a nine-month follow-up will help provide preliminary evidence of successful modification of disease trajectory over a one-year period
The IV route of administration will improve treatment access for a significant portion of patients with AS, PsA and nr-axSpA who are not comfortable with self-injections or simply prefer to receive treatments in their healthcare providers office, said Philip Mease, clinical professor at the University of Washington School of Medicine, in a prepared statement
Table 1 provides a non-exhaustive overview of the major microbes implicated in human AD with supporting evidence from both clinical and preclinical settings
The classic human studies used a weight-based intravenous dose of 2530 nmol/kg , given by slow IV injection
How to Get Started with Peptide Therapy Peptide therapy begins with a consultation to assess your health and determine the best treatment plan
That is not a criticism